Article info
PDFClinical
Original research
Clinical efficacy and tolerability of 1.5 g/day oral amoxicillin therapy without probenecid for the treatment of syphilis
- Correspondence to Dr Kazuaki Fukushima, Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku 113-8677, Japan; fukushima-ngi{at}umin.ac.jp
Citation
Clinical efficacy and tolerability of 1.5 g/day oral amoxicillin therapy without probenecid for the treatment of syphilis
Publication history
- Received October 6, 2020
- Revised March 8, 2021
- Accepted March 12, 2021
- First published March 29, 2021.
Online issue publication
April 12, 2022
Article Versions
- Previous version (29 March 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.